In 2007, a case between Insmed and Tercica was settled when the jury found that Insmed infringed patents licensed to Tercica for Increlex.
In 2007, Insmed and Tercica reached an agreement after the jury decided that Insmed had violated patents related to Increlex that were licensed by Tercica.